Health Services · Medical/Nursing Services · NSE: NEPHROPLUS · data 2026-10-09

Nephrocare Health Services Limited

Health check: Strong (7.8/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹616.4

Market cap

₹6,291 cr

P/E

—

P/B

—

ROE

9.0%

ROCE

14.6%

Debt / equity

0.07

Dividend yield

0.00%

1-year return

25.8%

52-week high

₹781.5

52-week low

₹446

Operating margin

—

Growth

Revenue (last 12 months)	—
Net profit (last 12 months)	—
Sales growth, 3 years (yearly)	31.6%
Profit growth, 3 years (yearly)	—

Chart patterns

Double top — breakdown (key level ₹618)

Similar companies

Dr. Agarwal's Health Care Ltd. (AGARWALEYE) · Vijaya Diagnostic Centre Ltd. (VIJAYA) · Metropolis Healthcare Ltd. (METROPOLIS) · Thyrocare Technologies Ltd (THYROCARE) · Jeena Sikho Lifecare Limited (JSLL)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open NEPHROPLUS in NSE Scanner →